Skip to content

Clinical trials

Terminated Arthritis, Rheumatoid trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arthritis, Rheumatoid Status: Terminated Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20111
20152
20191
20201
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
BeiGene1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
DePuy International1
Eli Lilly and Company1
Pfizer1
RemeGen Co., Ltd.1
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.1
Smith & Nephew Medical (Shanghai) Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis, Rheumatoid10
Osteoarthritis2
Arthritis1
Autoimmune Diseases1
Collagen Diseases1
Connective Tissue Diseases1
Femoral Neck Fractures1
Femur Head Necrosis1
Hereditary Sensory and Autonomic Neuropathies1
Hip Dislocation1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.